Company: ARTL
Filing Date: 2025-09-30
Form Type: 424B5
Source: 0001640334-25-001749
Chunk: 62

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-09-30
Form: 424B5
Chunk 62
---
 securities (by their acceptance of the debt securities) irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or other proceeding in the courts specified above and irrevocably and unconditionally waive and agree not to plead or claim any such suit, action or other proceeding has been brought in an inconvenient forum.

| 16 |

<div align='center'>DESCRIPTION OF WARRANTS</div>

We may issue warrants to purchase preferred stock or common stock. We may offer warrants separately or together with one or more additional warrants, preferred stock or common stock, or any combination of those securities in the form of units, as described in the applicable prospectus supplement. If we issue warrants as part of a unit, the applicable prospectus supplement will specify whether those warrants may be separated from the other securities in the unit prior to the expiration date of the warrants. The applicable prospectus supplement will also describe the following terms of any warrants:

| · | the specific designation and aggregate number of, and the offering price at which we will issue, the warrants;                                                                                                                                                |
| · | the currency or currency units in which the offering price, if any, and the exercise price are payable;                                                                                                                                                       |
| · | the date on which the right to exercise the warrants will begin and the date on which that right will expire or, if you may not continuously exercise the warrants throughout that period, the specific date or dates on which you may exercise the warrants; |
| · | whether the warrants are to be sold separately or with other securities as parts of units;                                                                                                                                                                    |
| · | whether the warrants will be issued in definitive or global form or in any combination of these forms, although, in any case, the form of a warrant included in a unit will correspond to the form of the unit and of any security included in that unit;     |
| · | any applicable material U.S. federal income tax consequences;                                                                                                                                                                                                 |
| · | the identity of the warrant agent for the warrants, if any, and of any other depositaries, execution or paying agents, transfer agents, registrars or other agents;                                                                                           |
| · | the proposed listing, if any, of the warrants or any securities purchasable upon exercise of the warrants on any securities exchange;                                                                                                                         |
| · | the designation and terms of any equity securities purchasable upon exercise of the warrants;                                                                                                                                                                 |
| · | if applicable, the designation and terms of the preferred stock or common stock with which the warrants are